Skip to content

ValueAct Holdings, L.P.: EXPE position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ValueAct Holdings, L.P. on EXPE, newest first. How the timeline and the estimate are built.

ValueAct Holdings, L.P. held 0 EXPE shares at 2025-09-30 per its 13F-HR filed 2025-11-14.

the latest 13F is the newest step

  1. period ended2025-09-30
    13F 0 shares
    Change vs previous 13F -278,356 shares

    13F-HR 0001418814-25-000003 filed by ValueAct Holdings, L.P.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  2. period ended2025-06-30
    13F 278,356 shares
    Change vs previous 13F -838,800 shares

    0.84% of the 13F portfolio, value $46,953,090.

    13F-HR 0001418812-25-000025 filed by ValueAct Holdings, L.P.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-03-31
    13F 1,117,156 shares
    Change vs previous 13F -900,250 shares

    4.1% of the 13F portfolio, value $187,793,924.

    13F-HR 0001418812-25-000015 filed by ValueAct Holdings, L.P.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2024-12-31
    13F 2,017,406 shares
    Change vs previous 13F -590,200 shares

    8.56% of the 13F portfolio, value $375,903,260.

    13F-HR 0001418812-25-000004 filed by ValueAct Holdings, L.P.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2024-09-30
    13F/A 2,607,606 shares
    Change vs previous 13F not available

    8.82% of the 13F portfolio, value $385,977,840.

    13F-HR/A 0001418812-24-000022 filed by ValueAct Holdings, L.P.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).